Affiliation:
1. Department of Ophthalmology, Renji Hospital, Shanghai Jiao Tong University School of Medicine
2. University of Melbourne
3. Centre for Eye and Vision Research (CEVR), The Hong Kong Polytechnic University
Abstract
Abstract
Background
Alzheimer’s disease (AD) is a progressive neurodegenerative disease with an increasing fatality rate and population burden. Previously, retinal vascular parameters have been linked to AD, suggesting assessment of retinal vascular parameters may offer a new target for screening patients at risk of AD.
Aim
To investigate the association between retinal arteriolar branching geometry and risk for Alzheimer’s disease.
Design and Setting:
Retrospective analysis of cohort study.
Methods
Participants of the UK Biobank with gradable fundoscopy images and free of AD at baseline were included for analyses. Retina-based Microvascular Health Assessment System (RMHAS) was applied to retinal images to segment arterioles and quantify retinal arteriolar branching parameters (angular asymmetry, AA, and branching coefficient, BC). Cox proportional hazards regression models investigated the associations between retinal arteriolar branching parameters as continuous and categorical variables in quantiles and incident AD.
Results
We included a total of 29,483 participants. 83(0.28%) participants developed AD during a median of 10.98 years. When modeled as continuous variables, angular asymmetry, and branching coefficient were significantly associated with Alzheimer’s disease (HR = 5.05, 95% CI = 1.82–14.1, P = 0.002; HR = 0.14, 95% CI = 0.02–0.75, P = 0.022, respectively). Such associations were also valid when BC and AA were analyzed as categorical variables (smallest quartile vs biggest three quartiles; HR = 2.97, 95% CI = 1.47–6.02, P = 0.002; HR = 0.43, 95% CI = 0.23–0.83; P = 0.012). Increased retinal arteriolar angular asymmetry and decreased branching coefficient conferred a long-term risk of AD.
Conclusions
This study found a significant association between retinal arteriolar branching geometry and the risk of AD, suggesting its potential value as a biomarker for AD.
Publisher
Research Square Platform LLC
Reference44 articles.
1. 1. 2022 Alzheimer's disease facts and figures. Alzheimers Dement. 2022;18(4):700 − 89.
2. 2. Cullen NC, Leuzy A, Janelidze S, Palmqvist S, Svenningsson AL, Stomrud E, et al. Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations. Nat Commun. 2021;12(1):3555.
3. 3. Diogo VS, Ferreira HA, Prata D, Alzheimer's Disease Neuroimaging I. Early diagnosis of Alzheimer's disease using machine learning: a multi-diagnostic, generalizable approach. Alzheimers Res Ther. 2022;14(1):107.
4. 4. Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414 − 30.
5. 5. Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Palsson E, et al. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. JAMA Psychiatry. 2014;71(10):1183-91.